Fundraising Fox

Fable

1 known investors

fabletherapeutics.com ↗

Fable Therapeutics develops biologics for metabolic disease treatment, specifically targeting the ActR2 pathway to address obesity and related comorbidities through protein engineering. The company is advancing a pipeline of therapeutic candidates designed to reduce body weight and fat while preserving muscle and improving metabolic health.

BiotechHealthtechMedical Devices

Investors · 1

MPM BioImpactBoston

In the news